$21.93
0.452.09%
At Close: -
$22.23
0.31.37%
After Hours: 3:47 PM EDT
15 minutes delayed
Arcturus Therapeutics
ARCTNASDAQ
Arcturus Therapeutics (ARCT) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestArcturus Therapeutics (NASDAQ:ARCT) 주식 시세 및 뉴스 요약
Arcturus Therapeutics 주식 (NASDAQ: ARCT) 주가, 뉴스, 차트, 주식 조사, 프로필.
| Open | $21.57 |
| Close | $21.93 |
| Volume / Avg. | 495.70K / 606.70K |
| Day Range | 21.06 - 22.22 |
| 52 Wk Range | 17.52 - 45.00 |
| Market Cap | $598.69M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 32 |
| Short Interest | 25.59% |
| Days to Cover | 5.9 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Arcturus Therapeutics Holdings Inc
Sector
Health Care
Industry
Biotechnology
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare dise...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Arcturus Therapeutics (ARCT) stock?
You can purchase shares of Arcturus Therapeutics (NASDAQ:ARCT) through any online brokerage.
Who are Arcturus Therapeutics (ARCT) competitors?
Other companies in Arcturus Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), PepGen (NASDAQ:PEPG) and Replimune Group (NASDAQ:REPL).
What is the target price for Arcturus Therapeutics (ARCT) stock?
There is no analysis for Arcturus Therapeutics.
What is the forecast for Arcturus Therapeutics (ARCT) stock?
Arcturus Therapeutics has a consensus price target of $44.14.
Current stock price for Arcturus Therapeutics (ARCT)?
The stock price for Arcturus Therapeutics (NASDAQ: ARCT) is $22.23 last updated July 3, 2024 at 3:47 PM EDT.
Does Arcturus Therapeutics (ARCT) pay a dividend?
There are no upcoming dividends for Arcturus Therapeutics.
When is Arcturus Therapeutics (NASDAQ:ARCT) reporting earnings?
Arcturus Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
Is Arcturus Therapeutics (ARCT) going to split?
There is no upcoming split for Arcturus Therapeutics.
What sector and industry does Arcturus Therapeutics (ARCT) operate in?
Arcturus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.